Tower Research Capital (TRC)’s Fractyl Health GUTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.9K	Buy	+27,628	New	+$19.7K	﹤0.01%	3466
2026 Q1	–	Sell	-14,768	Closed	-$32.5K	–	5640
2025 Q4	$32.5K	Buy	14,768 +9,559	+184%	+$15.4K	﹤0.01%	2749
2025 Q3	$8.28K	Buy	5,209 +2,414	+86%	+$3.13K	﹤0.01%	4053
2025 Q2	$4.53K	Sell	2,795 -5,509	-66%	-$8.9K	﹤0.01%	4312
2025 Q1	$9.88K	Buy	8,304 +2,694	+48%	+$4.3K	﹤0.01%	3710
2024 Q4	$11.6K	Buy	5,610 +862	+18%	+$2.01K	﹤0.01%	3699
2024 Q3	$12K	Buy	4,748 +3,656	+335%	+$11.9K	﹤0.01%	3628
2024 Q2	$4.66K	Sell	1,092 -4,357	-80%	-$28K	﹤0.01%	4752
2024 Q1	$40.3K	Buy	+5,449	New	+$45.9K	﹤0.01%	2422

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s GUTS Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Fractyl Health (GUTS) in Q2 2026: 27,628 shares worth $21.9K. The stake represents ﹤0.01% of the portfolio and ranks #3466 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in GUTS as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $40.3K in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Tower Research Capital (TRC) held 27,628 shares of Fractyl Health worth $21.9K as of Q2 2026.
Fractyl Health was a new Tower Research Capital (TRC) position in Q2 2026.
Fractyl Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3466 holding.
Tower Research Capital (TRC) first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
Tower Research Capital (TRC)'s Fractyl Health position peaked at $40.3K in Q1 2024.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.